SCHEMBL22415212

SCHEMBL22415212

CCCCC(CCC)CCN1CCNCC1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 4/20 0.40
GNAO1 P09471 6/20 0.39
GNAI3 P08754 5/20 0.39
GNAI1 P63096 5/20 0.39
CXCR4 P61073 2/20 0.39
POLB P06746 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
SOD3 P08294 2/20 0.35
HRH2 P25021 1/20 0.35
HRH1 P35367 1/20 0.35
TLR8 Q9NR97 1/20 0.33
TLR7 Q9NYK1 1/20 0.33
CHRM2 P08172 1/20 0.33
CHRM4 P08173 1/20 0.33
CHRM5 P08912 1/20 0.33
CHRM1 P11229 1/20 0.33
CHRM3 P20309 1/20 0.33
USP2 O75604 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22415173 0.93 POLB (0.41) SIGMAR1GNAO1GNAI3GNAI1CXCR4
SCHEMBL22430327 0.91 GNAO1 (0.45) SIGMAR1GNAO1GNAI3GNAI1CXCR4
SCHEMBL23132579 0.89 GNAO1 (0.46) SIGMAR1GNAO1GNAI3GNAI1CXCR4
SCHEMBL18773834 0.89 GNAO1 (0.46) SIGMAR1GNAO1GNAI3GNAI1CXCR4
SCHEMBL27811670 0.85 POLB (0.38) SIGMAR1GNAO1GNAI3GNAI1CXCR4
SCHEMBL9236820 0.84 GNAO1 (0.47) SIGMAR1GNAO1GNAI3GNAI1CXCR4
SCHEMBL21361983 0.83 HRH3 (0.38) GNAO1GNAI3GNAI1CHRM2CHRM1
SCHEMBL21348729 0.82 CXCR4 (0.43) SIGMAR1GNAO1GNAI3GNAI1CXCR4
SCHEMBL17526835 0.81 CXCR4 (0.40) SIGMAR1GNAO1GNAI3GNAI1CXCR4
SCHEMBL17526564 0.81 CXCR4 (0.40) SIGMAR1GNAO1GNAI3GNAI1CXCR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3705474-A1 PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF ACUTE MYELOID LEUKEMIA OR METASTATIC BREAST CANCER Pelemed Co., Ltd. (KR) 2020-09-09 EP disclosed